KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Equity Average (2019 - 2026)

GoodRx Holdings' Equity Average history spans 7 years, with the latest figure at $608.5 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 14.36% to $608.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $608.5 million, a 14.36% decrease, with the full-year FY2025 number at $670.5 million, down 9.8% from a year prior.
  • Equity Average hit $608.5 million in Q4 2025 for GoodRx Holdings, down from $621.9 million in the prior quarter.
  • Over the last five years, Equity Average for GDRX hit a ceiling of $888.3 million in Q3 2023 and a floor of $608.5 million in Q4 2025.
  • Historically, Equity Average has averaged $755.4 million across 5 years, with a median of $794.2 million in 2021.
  • Biggest five-year swings in Equity Average: skyrocketed 718.06% in 2021 and later decreased 24.52% in 2024.
  • Tracing GDRX's Equity Average over 5 years: stood at $839.0 million in 2021, then fell by 4.46% to $801.6 million in 2022, then rose by 2.5% to $821.6 million in 2023, then decreased by 13.52% to $710.5 million in 2024, then fell by 14.36% to $608.5 million in 2025.
  • Business Quant data shows Equity Average for GDRX at $608.5 million in Q4 2025, $621.9 million in Q3 2025, and $648.7 million in Q2 2025.